financetom
Business
financetom
/
Business
/
Core Scientific, Bitcoin Miners Tumble on CoreWeave Buyout; Jefferies Says Price in Expected Range
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Core Scientific, Bitcoin Miners Tumble on CoreWeave Buyout; Jefferies Says Price in Expected Range
Jul 7, 2025 9:16 AM

AI infrastructure firm CoreWeave ( CRWV ) has agreed to buy bitcoin (BTC) miner Core Scientific ( CORZ ) in an all-stock deal valuing CORZ at approximately $20.40 per share, based on recent closing prices.

The offer price is near the middle of investment bank Jefferies’ prior estimated takeout range of $16–$23/share. The deal is expected to close in Q4 2025.

Core Scientific ( CORZ ) shares were 22% lower, trading around $14 at publication time, while fellow bitcoin miners and possible high performance computing plays like HUT 8 ( HUT ) and Cleanspark ( CLSK ) were down more than 7%. Another similarly-situated miner, IREN (IREN), however, was higher by 3%.

Coreweave ( CRWV ) shares were lower by 3.3%.

Jefferies analysts previously noted that CoreWeave's ( CRWV ) strong post-IPO share performance put it in a favorable position to pursue large-scale M&A. The bank sees the move as a strategic effort to vertically integrate CoreWeave’s infrastructure and reduce reliance on long-term leases and third-party developers.

CoreWeave ( CRWV ) is well-positioned to use its relatively low cost of equity to replace long-term lease obligations and take direct control of data center assets, analysts Jonathan Petersen and Jan Aygul wrote.

The deal underscores the accelerating trend of consolidation in the AI infrastructure and high-performance computing (HPC) space, as vertically integrated providers seek scale and control.

For CoreWeave ( CRWV ), the move positions it as not just a supplier of compute, but a full-stack infrastructure operator, an increasingly critical posture as demand from AI firms and cloud-native enterprises continues to surge.

Acquiring Core Scientific's ( CORZ ) data center capacity and platform allows CoreWeave ( CRWV ) to expand owned infrastructure and better control future capacity expansion, the analysts said.

Core Scientific ( CORZ ) has also been seeking new leases with hyperscalers, and the analysts suggested that CoreWeave ( CRWV ) may be aiming to secure that space before new deals are finalized.

Jefferies has a buy rating on Core Scientific ( CORZ ) shares with an $18 price target.

Read more: CoreWeave ( CRWV ) to Acquire Core Scientific in $9B All-Stock Deal

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fastly Insider Sold Shares Worth $578,551, According to a Recent SEC Filing
Fastly Insider Sold Shares Worth $578,551, According to a Recent SEC Filing
May 20, 2024
05:15 PM EDT, 05/20/2024 (MT Newswires) -- Todd Nightingale, Director, CEO, on May 16, 2024, sold 65,447 shares in Fastly (FSLY) for $578,551. Following the Form 4 filing with the SEC, Nightingale has control over a total of 1,741,181 shares of the company, with 1,741,181 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1517413/000151741324000119/xslF345X03/wk-form4_1716239525.xml Price: 8.65, Change: -0.11, Percent Change: -1.26 ...
Truth Social owner sees wider loss in the first quarter
Truth Social owner sees wider loss in the first quarter
May 20, 2024
May 20 (Reuters) - Trump Media and Technology Group ( DJT ) , the operator of the social media app Truth Social, saw a wider loss in the first quarter due to certain non-cash expenses it incurred prior to closing its merger with a blank-check company. Net loss for the three months ended March 31 was $327.6 million, the company...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
May 20, 2024
May 20 (Reuters) - GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug. In a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims Act by hiding the risks for nearly four decades while...
GameStop, AMC Entertainment Shares Spike Monday Afternoon: What's Going On?
GameStop, AMC Entertainment Shares Spike Monday Afternoon: What's Going On?
May 20, 2024
Original meme stocks GameStop Corp ( GME ) and AMC Entertainment Holdings Inc ( AMC ) perked up in late trading Monday afternoon on no apparent news. The movement appears to be a continuation from last week’s retail investor momentum. What To Know: Although GameStop ( GME ) and AMC shares have been trending lower in recent trading sessions, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved